Radiographic Enhancing Progression Without Molecular or Histologic Progression in IDH-Mutant Grade 2 Astrocytoma Treated With an IDH Inhibitor: A Case Report. [PDF]
Pusec C +6 more
europepmc +1 more source
RETRACTION: LINC01614: A Potential Therapeutic Target in Astrocytoma Progression. [PDF]
europepmc +1 more source
Exceptional Long-Term Disease Stability Under Nivolumab in Recurrent High-Grade Glioma: A Case Report. [PDF]
Santos JN +9 more
europepmc +1 more source
Astrocytoma-Specific Prognostic Associations of Amyloid-Related Biological Processes. [PDF]
Narvaez Irizarry FY +3 more
europepmc +1 more source
Tumor-type-specific expression of TTF-1 in primary central nervous system tumors classified by the 2021 WHO criteria. [PDF]
Xu L +8 more
europepmc +1 more source
Occipital lobe glial and glioneuronal tumors: A systematic review of clinical presentation, surgical management, and outcomes. [PDF]
Al-Shalchy AK +2 more
europepmc +1 more source
DNA copy number patterns reveal prognostic markers and elucidate mechanisms of evolution in IDH-mutant astrocytoma. [PDF]
Drucker KL +19 more
europepmc +1 more source
Solitary left frontotemporal neuroendocrine metastasis mimicking a high-grade astrocytoma. [PDF]
González IZ, Paulino J.
europepmc +1 more source
Triple metachronous primary brain tumors: sequential occurrence of astrocytoma, atypical meningioma, and high-grade glioma without radiotherapy exposure. Illustrative case. [PDF]
Wang F +7 more
europepmc +1 more source

